Activated TBK1 phosphorylates IRF3, promoting its nuclear translocation and initiating IFN-α/β transcription, which rapidly recruits CD8+ T cells and NK cells to elicit anti-tumor effects (12, 13). Here, IRF3 is linked to neoplasm.